Nabla Bio | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

---

Nabla Bio is a biotechnology company based in Cambridge, Massachusetts, focused on designing antibodies with atomic precision using AI and wet-lab technologies. The company collaborates with leading pharmaceutical firms to develop drugs against previously undruggable targets, aiming to significantly increase the number of disease-relevant drug candidates in the industry. Founded in 2021, Nabla has raised $37 million from prominent investors and continues to recruit top talent in machine learning and synthetic biology.

🛍️ Nabla Bio Product and Pricing News →

👔 Nabla Bio CEO, Management and Leadership Team →

⚔️ Nabla Bio Alternatives and Competitors →

💼 Nabla Bio Hiring and Layoffs →

🤖 Nabla Bio Developer, Integration and Automation News →

📈 Nabla Bio Financials, Fundraising and Valuation News →

---

🛍️ Nabla Bio Product and Pricing News

---

👔 Nabla Bio CEO, Management and Leadership Team

• Surge Biswas

  
  Co-founder & CEO
  [email protected]

---

⚔️ Nabla Bio Alternatives and Competitors

• Proteros
|
• Biomatter
|
• Beryllium
|
• Matchpoint Therapeutics
|
• NextRNA Therapeutics
|
• Catamaran Bio
|
• 1910 Genetics
|
• Ultivue
|
• Ohana Biosciences
|
• Matterworks
|
• Arbor Biotechnologies
|
• Arctic Therapeutics
|
• Integral Molecular
|
• Abridge
|
• Pieces
|
• Healthie
|
• Climax Foods
|
• Generate Biomedicines
|
• BigHat
|
• Absci
|
• Koneksa
|
• Mingdu Zhiyun (Zhejiang) Technology
|
• OneCyte Biotechnologies
|
• Essence Information Technology

---

💼 Nabla Bio Hiring and Layoffs

---

🤖 Nabla Bio Developer, Integration and Automation News

---

📈 Nabla Bio Financials, Fundraising and Valuation News

---

People also viewed

• Generate Biomedicines
|
• Profluent
|
• Arzeda
|
• Biomatter
|
• Latent Labs
|
• Ledger
|
• Manta Network